Literature DB >> 34266601

Kallmann syndrome and idiopathic hypogonadotropic hypogonadism: The role of semaphorin signaling on GnRH neurons.

Anna Cariboni1, Ravikumar Balasubramanian2.   

Abstract

Idiopathic hypogonadotropic hypogonadism and Kallmann syndrome are rare genetic disorders characterized by isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) and delayed or absent puberty. Defective GnRH neuron migration during development or secretion of mature GnRH neurons secondary to molecular defects in several key developmental and neuroendocrine pathways are thought to be the primary causes of these disorders. Recent studies have highlighted the importance of semaphorins and their receptors in this system, by showing that these molecules play distinct roles during the development and plasticity of these neurons. Accordingly, mutations in the semaphoring-signaling pathway genes have been found in patients affected by IGD, underlying the importance of semaphorin-mediated signaling pathways in the neuroendocrine axis that control reproduction.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GnRH neurons; Hypogonadotropic hypogonadism; Hyposmia; Kallmann syndrome; Mutations; Oligogenicity; Semaphorins

Mesh:

Substances:

Year:  2021        PMID: 34266601      PMCID: PMC9039773          DOI: 10.1016/B978-0-12-819973-2.00022-8

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  59 in total

Review 1.  Deciphering genetic disease in the genomic era: the model of GnRH deficiency.

Authors:  Gerasimos P Sykiotis; Nelly Pitteloud; Stephanie B Seminara; Ursula B Kaiser; William F Crowley
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

2.  Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin.

Authors:  Kazuhiro Suzuki; Tatsusada Okuno; Midori Yamamoto; R Jeroen Pasterkamp; Noriko Takegahara; Hyota Takamatsu; Tomoe Kitao; Junichi Takagi; Paul D Rennert; Alex L Kolodkin; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

3.  Next-generation sequencing of patients with congenital anosmia.

Authors:  Anna Alkelai; Tsviya Olender; Catherine Dode; Sagit Shushan; Pavel Tatarskyy; Edna Furman-Haran; Valery Boyko; Ruth Gross-Isseroff; Matthew Halvorsen; Lior Greenbaum; Roni Milgrom; Kazuya Yamada; Ayumi Haneishi; Ilan Blau; Doron Lancet
Journal:  Eur J Hum Genet       Date:  2017-11-13       Impact factor: 4.246

Review 4.  Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.

Authors:  Ulrich Boehm; Pierre-Marc Bouloux; Mehul T Dattani; Nicolas de Roux; Catherine Dodé; Leo Dunkel; Andrew A Dwyer; Paolo Giacobini; Jean-Pierre Hardelin; Anders Juul; Mohamad Maghnie; Nelly Pitteloud; Vincent Prevot; Taneli Raivio; Manuel Tena-Sempere; Richard Quinton; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2015-07-21       Impact factor: 43.330

5.  Development of the somatosensory cortex, the cerebellum, and the main olfactory system in Semaphorin 3F knockout mice.

Authors:  Ikuo Matsuda; Masahiro Fukaya; Harumi Nakao; Kazuki Nakao; Hideyuki Matsumoto; Kensaku Mori; Masahiko Watanabe; Atsu Aiba
Journal:  Neurosci Res       Date:  2009-12-16       Impact factor: 3.304

Review 6.  Central hypogonadotropic hypogonadism: genetic complexity of a complex disease.

Authors:  Marco Marino; Valeria Moriondo; Eleonora Vighi; Elisa Pignatti; Manuela Simoni
Journal:  Int J Endocrinol       Date:  2014-09-01       Impact factor: 3.257

Review 7.  Update on the Genetics of Idiopathic Hypogonadotropic Hypogonadism.

Authors:  A Kemal Topaloğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

8.  De novo mutations in schizophrenia implicate synaptic networks.

Authors:  Menachem Fromer; Andrew J Pocklington; David H Kavanagh; Hywel J Williams; Sarah Dwyer; Padhraig Gormley; Lyudmila Georgieva; Elliott Rees; Priit Palta; Douglas M Ruderfer; Noa Carrera; Isla Humphreys; Jessica S Johnson; Panos Roussos; Douglas D Barker; Eric Banks; Vihra Milanova; Seth G Grant; Eilis Hannon; Samuel A Rose; Kimberly Chambert; Milind Mahajan; Edward M Scolnick; Jennifer L Moran; George Kirov; Aarno Palotie; Steven A McCarroll; Peter Holmans; Pamela Sklar; Michael J Owen; Shaun M Purcell; Michael C O'Donovan
Journal:  Nature       Date:  2014-01-22       Impact factor: 49.962

9.  SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome.

Authors:  Naresh Kumar Hanchate; Paolo Giacobini; Pierre Lhuillier; Jyoti Parkash; Cécile Espy; Corinne Fouveaut; Chrystel Leroy; Stéphanie Baron; Céline Campagne; Charlotte Vanacker; Francis Collier; Corinne Cruaud; Vincent Meyer; Alfons García-Piñero; Didier Dewailly; Christine Cortet-Rudelli; Ksenija Gersak; Chantal Metz; Gérard Chabrier; Michel Pugeat; Jacques Young; Jean-Pierre Hardelin; Vincent Prevot; Catherine Dodé
Journal:  PLoS Genet       Date:  2012-08-23       Impact factor: 5.917

10.  Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex.

Authors:  Paolo Giacobini; Andrea Messina; Francesca Morello; Nicoletta Ferraris; Simona Corso; Junia Penachioni; Silvia Giordano; Luca Tamagnone; Aldo Fasolo
Journal:  J Cell Biol       Date:  2008-11-03       Impact factor: 10.539

View more
  1 in total

1.  Treatment of congenital hypogonadotropic hypogonadism in male patients.

Authors:  Hae Sang Lee; Young Suk Shim; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.